Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ DAPK3/ZIPK Antibody Blocking Peptide
SDP

Catalog No. NBP176962E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP176962E 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP176962E Supplier Novus Biologicals™ Supplier No. NBP176962PEP
Only null left
Add to Cart
Add to Cart

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 20 amino acids near the center of center of human ZIPK. Source: Synthetic (Accession #: BAA81746) The DAPK3/ZIPK Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 1613
Species Human
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-76962. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias DAP kinase 3, DAP-like kinase, death-associated protein kinase 3, dlk, EC 2.7.11, EC 2.7.11.1, ZIP, ZIP kinase isoform, ZIPKFLJ36473, ZIP-kinase
Gene Symbol DAPK3
Product Type DAPK3/ZIPK
Quantity 0.05 mg
Regulatory Status RUO - research use only
Source Synthetic
Termination 20 amino acids near the center of human ZIPK
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.